Concepedia

Michael Hettich

MH

Statistics

Publications

9

Citations

1.3K

H-Index

9

Active since

2005

Affiliations

University of Freiburg(Current)

Heidelberg University

University Medical Center Freiburg

German Cancer Research Center

University Hospital Heidelberg

Michael Hettich is an author at University of Freiburg specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

2005–2019

9

Publications

9

Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy

Christina Claus, Claudia Ferrara, Wei Xu et al. · Science Translational Medicine · 2019 · 266 citations · Full text

, , +17

Oncogenic JAK2 <sup>V617F</sup> causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms

Alessandro Prestipino, Alica Joana Emhardt, Konrad Aumann et al. · Science Translational Medicine · 2018 · 224 citations

, , +17

High-Resolution PET Imaging with Therapeutic Antibody-based PD-1/PD-L1 Checkpoint Tracers

Michael Hettich, Friederike Braun, Mark Bartholomä et al. · Theranostics · 2016 · 193 citations · Full text

, , +17

Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity

Florian Kaestner, Michael Hettich, Marion Peters et al. · Journal of Affective Disorders · 2005 · 178 citations

, , +17

Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57

Xuekai Zhu, Shruthi Prasad, Simone Gaedicke et al. · Oncotarget · 2014 · 157 citations · Full text

, , +17

1–5 of 9